Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Specific immunotherapy. Hyposensitization with allergens].

B Wedi1, A Kapp

  • 1Klinik und Poliklinik für Dermatologie und Venerologie, Medizinische Hochschule Hannover, Hannover, Germany. Bettina_Wedi@t-online.de

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|May 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

Allergy·2026
Same author

Epidemiology, comorbidities, and healthcare utilization of patients with chronic urticaria in Germany.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

A rare case of neuro- and otosyphilis in secondary syphilis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Langerhans cell histiocytosis mimicking prurigo nodularis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Lanadelumab to treat hereditary angioedema.

Drugs of today (Barcelona, Spain : 1998)·2019
Same author

Neurological disorders are associated with bullous pemphigoid.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same journal

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral infections of the skin].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral exanthems in children].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Erratum to: Digital health applications and data protection].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Virus-induced exanthems in returning travellers].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Venous ulcus cruris-Surgical treatment].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
See all related articles

Allergen-specific immunotherapy (SIT) effectively reduces allergic reactions and prevents asthma development in children. This treatment modulates immune responses, offering long-term benefits for inhalant allergies and insect venom hypersensitivity.

Area of Science:

  • Immunology
  • Allergology
  • Clinical Medicine

Background:

  • Allergen-specific immunotherapy (SIT) is a crucial treatment for allergic diseases.
  • It induces immunological changes that reduce allergic inflammation.
  • SIT demonstrates long-term efficacy, particularly in mild inhalant allergies.

Purpose of the Study:

  • To summarize the efficacy and immunological mechanisms of SIT.
  • To highlight SIT's role in preventing further allergic sensitization and asthma.
  • To emphasize the importance of patient and allergen selection for SIT.

Main Methods:

  • Review of existing literature and clinical data on SIT.
  • Analysis of immunological changes associated with successful SIT.
  • Evaluation of SIT's effectiveness in various allergic conditions.

Related Experiment Videos

Main Results:

  • SIT leads to reduced allergic inflammatory reactions.
  • It is effective when pharmacotherapy fails and prevents asthma in children with allergic rhinitis.
  • SIT is the preferred treatment for systemic reactions to hymenoptera venoms.

Conclusions:

  • SIT modulates regulatory T cells and promotes IgG4 production.
  • Careful patient and allergen selection by allergology specialists is critical for SIT efficacy and safety.
  • Further research is ongoing to fully elucidate SIT's effector mechanisms.